News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sentigen Holding Corp. Announces Annual Results


10/19/2005 5:13:11 PM

PHILLIPSBURG, N.J.--(BUSINESS WIRE)--March 30, 2005--Sentigen Holding Corp. (NasdaqSC: SGHL), today reported results for the year and fourth quarter ended December 31, 2004. On February 22, 2005 we sold the Specialty Media Division of our wholly-owned subsidiary, Cell & Molecular Technologies, Inc. ("CMT") to Chemicon International, Inc., a wholly-owned subsidiary of Serologicals Corporation (Nasdaq: SERO). As such the annual results of this division have been accounted for as discontinued operations.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES